MOREPEN LABORATORIES
Back to Cashflow Statement
|
MOREPEN LABORATORIES Last 5 Year Cash Flow from Financing Activities History
[Consolidated]
| Mar2025 | Mar2024 | Mar2023 | Mar2022 | Mar2021 | |
|---|---|---|---|---|---|
| Cash Flow from Financing Activities | ₹300 Cr | ₹5.20 Cr | ₹144 Cr | ₹66 Cr | ₹47 Cr |
What is the latest Cash Flow from Financing Activities ratio of MOREPEN LABORATORIES ?
| Year | Cash Flow from Financing Activities |
|---|---|
| Mar2025 | ₹300 Cr |
| Mar2024 | ₹5.20 Cr |
| Mar2023 | ₹144 Cr |
| Mar2022 | ₹66 Cr |
| Mar2021 | ₹47 Cr |
How is Cash Flow from Financing Activities of MOREPEN LABORATORIES Trending?
| Years | Cash Flow from Financing Activities | % Change | |
|---|---|---|---|
| Mar2025 | ₹300 Cr | 5,661.50 | |
| Mar2024 | ₹5.20 Cr | -96.37 | |
| Mar2023 | ₹144 Cr | 116.39 | |
| Mar2022 | ₹66 Cr | 40.32 | |
| Mar2021 | ₹47 Cr | - | |
Compare Cash Flow from Financing Activities of peers of MOREPEN LABORATORIES
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| MOREPEN LABORATORIES | ₹4,615.3 Cr | 6.3% | 38.5% | 62.2% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹461,848.0 Cr | -1.4% | -1.3% | 21.5% | Stock Analytics | |
| DIVIS LABORATORIES | ₹225,648.0 Cr | 2.7% | 16.1% | 38.6% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹184,109.0 Cr | -1.5% | -3.3% | 35.6% | Stock Analytics | |
| CIPLA | ₹117,139.0 Cr | -0.7% | 1.4% | -2% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹100,328.0 Cr | 3.9% | -1.8% | 0.4% | Stock Analytics | |
MOREPEN LABORATORIES Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| MOREPEN LABORATORIES | 6.3% |
38.5% |
62.2% |
| SENSEX | -0.6% |
1.1% |
-3.2% |
You may also like the below Video Courses